SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Galirayo who wrote (10821)8/15/2005 11:20:13 PM
From: Jibacoa  Read Replies (1) of 23958
 
ENCY has had some good action in the last few days after the August 8 L at 11.36, that day the volume was 1,258.615.Today's upmove was on 944,071 which is the highest since then.

The stock needs to close above the resistance at 12.77 before it can test its August 2 H at 13.22 Revenues were better on the last Q, but the loss increased. On the September Q the revenues are expected to be better since in 2004 they were down 24% but the loss in the last 2Qs still isn't expected to show any improvement. (It is in 2006 when the expectations are for a significant cut on the loss.)

ENCY has filed for approval of Thelin for PAH in the U.S. and Europe and if gets an OK from the FDA as many people are expecting, the stock could have a nice move. (I don't have any problem waiting for further developments.<g>)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext